These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7334343)

  • 1. [Early clinical and histopathological manifestations in 14 boys showing elevated serum creatine-phosphokinase levels in their first year].
    Guibaud P; Carrier HN; Plauchu H; Lauras B; Jolivet MJ; Robert JM
    J Genet Hum; 1981 Mar; 29(1):71-84. PubMed ID: 7334343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for Duchenne muscular dystrophy.
    Zellweger H; Antonik A
    Pediatrics; 1975 Jan; 55(1):30-4. PubMed ID: 1110862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis between Duchenne and Becker types muscular dystrophy.
    Ishpekova B; Milanov I; Christova LG; Alexandrov AS
    Electromyogr Clin Neurophysiol; 1999; 39(5):315-8. PubMed ID: 10422002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systematic neonatal detection of Duchenne's muscular dystrophy. Results after 10 years' of experience in Lyons (France)].
    Plauchu H; Cordier MP; Carrier HN; Dellamonica C; Dorche C; Guibaud P; Lauras B; Cotte J; Robert JM
    J Genet Hum; 1987 Aug; 35(4):217-30. PubMed ID: 3655748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relations between delayed diagnosis and forms of onset in Duchenne muscular dystrophy].
    Alvarez Leal M; Morales Aguilera A; Pérez Zuno JA; Segura Romero S; Quiroz Góngora MC; Paredes García A
    Gac Med Mex; 1994; 130(6):459-64. PubMed ID: 7557061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal diagnosis of Duchenne's muscular dystrophy.
    Mahoney MJ; Haseltine FP; Hobbins JC; Banker BQ; Caskey CT; Golbus MS
    N Engl J Med; 1977 Nov; 297(18):968-73. PubMed ID: 909543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital muscular dystrophy.
    Huang FL; Mak SC; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):165-9. PubMed ID: 10677931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy.
    Golbus MS; Stephens JD; Mahoney MJ; Hobbins JC; Haseltine FP; Caskey CT; Banker BQ
    N Engl J Med; 1979 Apr; 300(15):860-1. PubMed ID: 423925
    [No Abstract]   [Full Text] [Related]  

  • 14. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital muscular dystrophy: a clinico-pathological and follow-up study of 15 patients.
    Donner M; Rapola J; Somer H
    Neuropadiatrie; 1975 Aug; 6(3):239-58. PubMed ID: 1242211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mathematical analysis of creatine kinase activity in the course of Duchenne muscular dystrophy.
    Pernice W; Guggolz MA; Guggolz M; Beckmann R; Wais U
    Muscle Nerve; 1986 May; 9(4):333-40. PubMed ID: 3713738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia.
    Ben Hamida M; Fardeau M; Attia N
    Muscle Nerve; 1983 Sep; 6(7):469-80. PubMed ID: 6633560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.
    Scheuerbrandt G; Lundin A; Lövgren T; Mortier W
    Muscle Nerve; 1986 Jan; 9(1):11-23. PubMed ID: 3951477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structural and ultrastructural changes in the skeletal muscles of patients in the early stages of Duchenne muscular dystrophy and "possible" carriers].
    Bucciolini Di Sagni MG; Vannelli Gori G; Oriolo RA
    Boll Soc Ital Biol Sper; 1982 May; 58(10):632-8. PubMed ID: 7115577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of preclinical Duchenne's muscular dystrophy in the newborn using the CK screening test].
    Beckmann R; Scheuerbrandt G; Antonik A
    Monatsschr Kinderheilkd (1902); 1976 Sep; 129(9):658-9. PubMed ID: 979985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.